Workflow
Coya Therapeutics setback
icon
Search documents
晨化股份: 第五届董事会第一次会议决议公告
Zheng Quan Zhi Xing· 2025-06-23 14:19
证券代码:300610 证券简称:晨化股份 公告编号:2025-060 扬州晨化新材料股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 扬州晨化新材料股份有限公司(以下简称"公司")于 2025 年 6 月 23 日 召开 2025 年第一次临时股东会,选举产生第五届董事会。为保证新一届董事会 工作的正常运行,经全体董事同意豁免会议通知时间要求,公司于同日下午在 江苏省宝应县淮江大道 999 号公司十一楼 1102 会议室召开第五届董事会第一次 会议。 本次会议应到董事 9 人,实到董事 9 人;公司高级管理人员列席了会议。 经全体董事推选,会议由董事于子洲先生主持。本次会议的召开符合《中华人 民共和国公司法》和《公司章程》的有关规定。 二、董事会会议审议情况 经与会董事投票表决,审议通过了如下决议: (一)审议通过了《关于选举公司第五届董事会董事长的议案》 经全体董事审议,同意选举于子洲先生为公司第五届董事会董事长,任期 三年,自本次董事会审议通过之日起至第五届董事会任期届满之日止。 审议结果:9 票同意,0 票反对,0 ...
淳中科技: 北京淳中科技股份有限公司2024年年度权益分派实施公告
Zheng Quan Zhi Xing· 2025-06-23 14:19
证券代码:603516 证券简称:淳中科技 公告编号:2025-031 北京淳中科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ? 每股分配比例 A 股每股现金红利0.25元 ? 相关日期 | 股份类别 | 股权登记日 | | 最后交易日 | 除权(息)日 | 现金红利发放日 | | --- | --- | --- | --- | --- | --- | | A股 | 2025/6/27 | - | 2025/6/30 | 2025/6/30 | | 二、 分配方案 ? 差异化分红送转: 是 一、 通过分配方案的股东会届次和日期 本次利润分配方案经公司2025 年 5 月 26 日的2024年年度股东会审议通过。 公司根据上海证券交易所的相关规定,将按照以下公式计算除权除息开盘参考价:除权 (息)参考价格=(前收盘价格-现金红利)÷(1+流通股份变动比例) 截至股权登记日下午上海证券交易所收市后,在中国证券登记结算有限责任公司上海分 公司(以下简称"中国结算上海分公司")登记在册的本公司全体股 ...
广州港: 广州港股份有限公司关于第四届董事会第二十六次会议决议的公告
Zheng Quan Zhi Xing· 2025-06-23 14:19
关于第四届董事会第二十六次会议决议的公告 证券代码:601228 证券简称:广州港 公告编号:2025-032 债券代码:185969.SH、137626.SH、137812.SH、115012.SH、240489.SH、243016.SH、243145.SH 债券简称:22 粤港 02、22 粤港 03、22 粤港 04、23 粤港 01、24 粤港 01、25 粤港 01、25 粤港 02 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会召开情况 (一)本次会议的召集、召开符合《中华人民共和国公司法》《公司章程》 及相关法律、法规的要求。 广州港股份有限公司 该议案已经公司第四届董事会战略委员会第四次会议审议通过,并同意提交 本次董事会会议审议。 表决结果:8 票同意,0 票反对,0 票弃权。 (二)会议通知已于 2025 年 6 月 17 日以书面或电子邮件方式送交公司全体 董事。 (三)会议时间:2025 年 6 月 23 日 16:20 会议地点:广州市越秀区沿江东路 406 号港口中心 2706 会议室 ...
C3.ai Ramps Up Partner-Led Sales Model: Can It Drive Scalable Growth?
ZACKS· 2025-06-23 14:15
Key Takeaways AI closed 73% of Q4 deals through partners, with 193 partner-led agreements signed in fiscal 2025. Partner bookings surged 419% in Q4, with 28 joint wins with Microsoft in key sectors. AI is jointly targeting 600 accounts with Microsoft while expanding alliances with AWS and Google Cloud.C3.ai, Inc. (AI) is doubling down on a go-to-market strategy centered around its rapidly expanding partner ecosystem. In the fourth quarter of fiscal 2025, the company secured 73% of its agreements in collab ...
Best Growth Stocks to Buy for June 23rd
ZACKS· 2025-06-23 14:15
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today June 23rd:Great Lakes Dredge & Dock (GLDD) These company which is the largest provider of dredging services in the US conducting business to maintain and deepen shipping channels, reclaim land from the ocean, and renourish storm damaged coastline, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 39.1% over the last 60 days.Great L ...
UGI's AmeriGas Propane to Divest Hawaii Assets by Fiscal Q4 2025
ZACKS· 2025-06-23 14:15
Key Takeaways UGI's AmeriGas is selling Hawaii propane assets to Isle Gas, with closing expected in Q4 fiscal 2025. The deal includes 750,000 gallons of storage and a delivery fleet, with proceeds used to reduce debt. UGI aims to boost efficiency and fund growth by exiting non-core markets and cutting long-term costs.UGI Corporation (UGI) announced that its subsidiary, AmeriGas Propane, L.P. (AmeriGas), has entered into a definitive agreement to divest some of its assets in Hawaii to Isle Gas, a wholly ow ...
J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications
ZACKS· 2025-06-23 14:15
Key Takeaways JNJ's Darzalex gets CHMP nod to treat high-risk smoldering multiple myeloma in adults. Imbruvica also earns CHMP support for frontline mantle cell lymphoma use with chemo. Both decisions are backed by phase III studies showing significant survival improvements.J&J (JNJ) announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended granting label expansion to its two key products, Darzalex and Imbruvica, across separate new indications.CHMP Endorses JNJ’s Darzal ...
Accenture (ACN) Reliance on International Sales: What Investors Need to Know
ZACKS· 2025-06-23 14:15
Have you evaluated the performance of Accenture's (ACN) international operations for the quarter ending May 2025? Given the extensive global presence of this consulting company, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For inves ...
Insights Into Lindsay (LNN) Q3: Wall Street Projections for Key Metrics
ZACKS· 2025-06-23 14:15
In its upcoming report, Lindsay (LNN) is predicted by Wall Street analysts to post quarterly earnings of $1.36 per share, reflecting a decline of 3.6% compared to the same period last year. Revenues are forecasted to be $162.01 million, representing a year-over-year increase of 16.4%.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Before a company reve ...
Ahead of Nike (NKE) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
ZACKS· 2025-06-23 14:15
The upcoming report from Nike (NKE) is expected to reveal quarterly earnings of $0.11 per share, indicating a decline of 89.1% compared to the year-ago period. Analysts forecast revenues of $10.67 billion, representing a decrease of 15.4% year over year.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.Ahead of a company's e ...